SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pilar Mur, Manuela Mollejo, Teresa Hernández-Iglesias, Ángel Rodríguez de Lope, Javier S. Castresana, Juan F. García, Concepción Fiaño, Teresa Ribalta, Juan A. Rey, Barbara Meléndez, Molecular Classification Defines 4 Prognostically Distinct Glioma Groups Irrespective of Diagnosis and Grade, Journal of Neuropathology & Experimental Neurology, 2015, 74, 3, 241

    CrossRef

  2. 2
    Christina L. Appin, Daniel J. Brat, Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic Diagnosis, Advances In Anatomic Pathology, 2015, 22, 1, 50

    CrossRef

  3. 3
    Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba, Yusuke Sato, Yusuke Shiozawa, Yuichi Shiraishi, Teppei Shimamura, Atsushi Niida, Kazuya Motomura, Fumiharu Ohka, Takashi Yamamoto, Kuniaki Tanahashi, Melissa Ranjit, Toshihiko Wakabayashi, Tetsuichi Yoshizato, Keisuke Kataoka, Kenichi Yoshida, Yasunobu Nagata, Aiko Sato-Otsubo, Hiroko Tanaka, Masashi Sanada, Yutaka Kondo, Hideo Nakamura, Masahiro Mizoguchi, Tatsuya Abe, Yoshihiro Muragaki, Reiko Watanabe, Ichiro Ito, Satoru Miyano, Atsushi Natsume, Seishi Ogawa, Mutational landscape and clonal architecture in grade II and III gliomas, Nature Genetics, 2015,

    CrossRef

  4. 4
    Sriram Venneti, Jason T. Huse, The Evolving Molecular Genetics of Low-grade Glioma, Advances In Anatomic Pathology, 2015, 22, 2, 94

    CrossRef

  5. 5
    Lale Erdem-Eraslan, Daphne Heijsman, Maurice de Wit, Andreas Kremer, Andrea Sacchetti, Peter J. van der Spek, Peter A. E. Sillevis Smitt, Pim J. French, Tumor-specific mutations in low-frequency genes affect their functional properties, Journal of Neuro-Oncology, 2015,

    CrossRef

  6. 6
    Macoura Gadji, Ana-Maria Crous-Tsanaclis, David Mathieu, Sabine Mai, David Fortin, Régen Drouin, A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component, Neuropathology, 2014, 34, 2
  7. 7
    Nadejda M. Tsankova, Peter Canoll, Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective, Journal of Neuro-Oncology, 2014, 119, 3, 481

    CrossRef

  8. 8
    Masaya Nagaishi, Aya Suzuki, Sumihito Nobusawa, Hideaki Yokoo, Yoichi Nakazato, Alpha-internexin and altered CIC expression as a supportive diagnostic marker for oligodendroglial tumors with the 1p/19q co-deletion, Brain Tumor Pathology, 2014, 31, 4, 257

    CrossRef

  9. 9
    François Ducray, Caroline Dehais, Jean-Yves Delattre, An overview of current and future treatment options for adults anaplastic oligodendroglial tumors, Expert Opinion on Orphan Drugs, 2014, 2, 8, 831

    CrossRef

  10. 10
    Debodipta Das, Inderjeet Kaur, Mohammad Javed Ali, Nidhan K. Biswas, Subrata Das, Shantanu Kumar, Santosh G. Honavar, Arindam Maitra, Subhabrata Chakrabarti, Partha P. Majumder, Exome Sequencing Reveals the Likely Involvement of SOX10 in Uveal Melanoma, Optometry and Vision Science, 2014, 91, 7, e185

    CrossRef

  11. 11
    Fred H Hochberg, Nadia A Atai, David Gonda, Michael S Hughes, Brolin Mawejje, Leonora Balaj, Robert S Carter, Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science, Expert Review of Molecular Diagnostics, 2014, 14, 4, 439

    CrossRef

  12. 12
    Miguel Torres-Martín, Carolina Peña-Granero, Fernando Carceller, Manuel Gutiérrez, Rommel R Burbano, Giovanny R Pinto, Javier S Castresana, Bárbara Melendez, Juan A Rey, Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component, Molecular Cytogenetics, 2014, 7, 1, 1

    CrossRef

  13. 13
    J. Beiko, D. Suki, K. R. Hess, B. D. Fox, V. Cheung, M. Cabral, N. Shonka, M. R. Gilbert, R. Sawaya, S. S. Prabhu, J. Weinberg, F. F. Lang, K. D. Aldape, E. P. Sulman, G. Rao, I. E. McCutcheon, D. P. Cahill, IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection, Neuro-Oncology, 2014, 16, 1, 81

    CrossRef

  14. 14
    Iva Simeonova, Emmanuelle Huillard, In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies, Cellular and Molecular Life Sciences, 2014, 71, 20, 4007

    CrossRef

  15. 15
    N. R. Smoll, B. Hamilton, Incidence and relative survival of anaplastic astrocytomas, Neuro-Oncology, 2014, 16, 10, 1400

    CrossRef

  16. 16
    Magdalena Megova, Jiri Drabek, Vladimira Koudelakova, Radek Trojanec, Ondrej Kalita, Marian Hajduch, Isocitrate dehydrogenase 1 and 2 mutations in gliomas, Journal of Neuroscience Research, 2014, 92, 12
  17. 17
    Christina L. Appin, Daniel J. Brat, Molecular Genetics of Gliomas, The Cancer Journal, 2014, 20, 1, 66

    CrossRef

  18. 18
    Robert Aiken, Molecular Neuro-oncology and the Challenge of the Blood-Brain Barrier, Seminars in Oncology, 2014, 41, 4, 438

    CrossRef

  19. You have free access to this content19
    Emmanouil Athanasakis, Danilo Licastro, Flavio Faletra, Antonella Fabretto, Savina Dipresa, Diego Vozzi, Anna Morgan, Adamo P. d'Adamo, Vanna Pecile, Xevi Biarnés, Paolo Gasparini, Next generation sequencing in nonsyndromic intellectual disability: From a negative molecular karyotype to a possible causative mutation detection, American Journal of Medical Genetics Part A, 2014, 164, 1
  20. 20
    Aya Suzuki, Sumihito Nobusawa, Atsushi Natsume, Hiromichi Suzuki, Young-Ho Kim, Hideaki Yokoo, Masaya Nagaishi, Hayato Ikota, Takuro Nakazawa, Toshihiko Wakabayashi, Hiroko Ohgaki, Yoichi Nakazato, Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas, Journal of Neuro-Oncology, 2014, 120, 2, 283

    CrossRef

  21. 21
    Kurt A. Jaeckle, Oligodendroglial Tumors, Seminars in Oncology, 2014, 41, 4, 468

    CrossRef

  22. 22
    Harry R. Haynes, Sandra Camelo-Piragua, Kathreena M. Kurian, Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment, Frontiers in Oncology, 2014, 4,

    CrossRef

  23. 23
    K. S. Panageas, A. S. Reiner, F. M. Iwamoto, T. F. Cloughesy, K. D. Aldape, A. L. Rivera, A. F. Eichler, D. N. Louis, N. A. Paleologos, B. J. Fisher, L. S. Ashby, J. G. Cairncross, G. B. Roldan Urgoiti, P. Y. Wen, K. L. Ligon, D. Schiff, H. I. Robins, B. G. Rocque, M. C. Chamberlain, W. P. Mason, S. A. Weaver, R. M. Green, F. G. Kamar, L. E. Abrey, L. M. DeAngelis, S. C. Jhanwar, M. K. Rosenblum, A. B. Lassman, Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors, Neuro-Oncology, 2014, 16, 11, 1541

    CrossRef

  24. 24
    Hinke F van Thuijl, Ilari Scheinin, Daoud Sie, Agusti Alentorn, Hendrik F van Essen, Martijn Cordes, Ruth Fleischeuer, Anja M Gijtenbeek, Guus Beute, Wimar A van den Brink, Gerrit A Meijer, Miek Havenith, Ahmed Idbaih, Khê Hoang-Xuan, Karima Mokhtari, Roel Verhaak, Paul van der Valk, Mark A van de Wiel, Jan J Heimans, Eleonora Aronica, Jaap C Reijneveld, Pieter Wesseling, Bauke Ylstra, Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas, Genome Biology, 2014, 15, 9, 471

    CrossRef

  25. 25
    M Labussière, A L Di Stefano, V Gleize, B Boisselier, M Giry, S Mangesius, A Bruno, R Paterra, Y Marie, A Rahimian, G Finocchiaro, R S Houlston, K Hoang-Xuan, A Idbaih, J-Y Delattre, K Mokhtari, M Sanson, TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations, British Journal of Cancer, 2014, 111, 10, 2024

    CrossRef

  26. 26
    Adriana Olar, Kenneth D Aldape, Using the molecular classification of glioblastoma to inform personalized treatment, The Journal of Pathology, 2014, 232, 2
  27. 27
    J. T. Huse, M. Wallace, K. D. Aldape, M. S. Berger, C. Bettegowda, D. J. Brat, D. P. Cahill, T. Cloughesy, D. A. Haas-Kogan, M. Marra, C. R. Miller, S. J. Nelson, S. R. Salama, R. Soffietti, P. Y. Wen, S. Yip, K. Yen, J. F. Costello, S. Chang, Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop, Neuro-Oncology, 2014, 16, 2, 173

    CrossRef

  28. 28
    Shirin Ilkhanizadeh, Jasmine Lau, Miller Huang, Daniel J. Foster, Robyn Wong, Aaron Frantz, Susan Wang, William A. Weiss, Anders I. Persson, 2014,

    CrossRef

  29. 29
    Timothy P. Kegelman, Bin Hu, Luni Emdad, Swadesh K. Das, Devanand Sarkar, Paul B. Fisher, 2014,

    CrossRef

  30. 30
    K. H. Clark, J. L. Villano, M. N. Nikiforova, R. L. Hamilton, C. Horbinski, 1p/19q testing has no significance in the workup of glioblastomas, Neuropathology and Applied Neurobiology, 2013, 39, 6
  31. 31
    F. Sahm, U. Lass, C. Herold-Mende, A. von Deimling, C. Hartmann, W. Mueller, Analysis of CIC-associated CpG island methylation in oligoastrocytoma, Neuropathology and Applied Neurobiology, 2013, 39, 7
  32. 32
    Pilar Mur, Manuela Mollejo, Yolanda Ruano, Ángel Rodríguez de Lope, Concepción Fiaño, Juan Fernando García, Javier S. Castresana, Aurelio Hernández-Laín, Juan A. Rey, Bárbara Meléndez, Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors, Acta Neuropathologica, 2013, 126, 2, 277

    CrossRef

  33. 33
    Solmaz Sahebjam, Mairéad G McNamara, Warren P Mason, Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management, CNS Oncology, 2013, 2, 4, 351

    CrossRef

  34. 34
    Gavin P. Dunn, Ovidiu C. Andronesi, Daniel P. Cahill, From genomics to the clinic: biological and translational insights of mutantIDH1/2in glioma, Neurosurgical Focus, 2013, 34, 2, E2

    CrossRef

  35. 35
    H.F. van Thuijl, B. Ylstra, T. Würdinger, D. van Nieuwenhuizen, J.J. Heimans, P. Wesseling, J.C. Reijneveld, Genetics and pharmacogenomics of diffuse gliomas, Pharmacology & Therapeutics, 2013, 137, 1, 78

    CrossRef

  36. 36
    Agusti Alentorn, Marianne Labussière, Marc Sanson, Jean-Yves Delattre, Khê Hoang-Xuan, Ahmed Idbaih, Génétique et gliomes cérébraux, La Presse Médicale, 2013, 42, 5, 806

    CrossRef

  37. 37
    Cristian Bellodi, Mary McMahon, Adrian Contreras, Dayle Juliano, Noam Kopmar, Tomoka Nakamura, David Maltby, Alma Burlingame, Sharon A. Savage, Akiko Shimamura, Davide Ruggero, H/ACA Small RNA Dysfunctions in Disease Reveal Key Roles for Noncoding RNA Modifications in Hematopoietic Stem Cell Differentiation, Cell Reports, 2013, 3, 5, 1493

    CrossRef

  38. 38
    Dakeun Lee, Yeon-Lim Suh, So Young Kang, Tae-In Park, Ji Yun Jeong, Se-Hoon Kim, IDH1 Mutations in Oligodendroglial Tumors: Comparative Analysis of Direct Sequencing, Pyrosequencing, Immunohistochemistry, Nested PCR and PNA-Mediated Clamping PCR, Brain Pathology, 2013, 23, 3
  39. 39
    C. Zhang, L. M. Moore, X. Li, W. K. A. Yung, W. Zhang, IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma, Neuro-Oncology, 2013, 15, 9, 1114

    CrossRef

  40. 40
    Aden Ka-Yin Chan, Jesse Chung-Sean Pang, Nellie Yuk-Fei Chung, Kay Ka-Wai Li, Wai Sang Poon, Danny Tat-Ming Chan, Zhifeng Shi, Liang Chen, Liangfu Zhou, Ho-Keung Ng, Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors, Modern Pathology, 2013,

    CrossRef

  41. 41
    Adam M. Fontebasso, Denise Bechet, Nada Jabado, Molecular biomarkers in pediatric glial tumors, Current Opinion in Oncology, 2013, 25, 6, 665

    CrossRef

  42. 42
    Pamela S. Jones, Gavin P. Dunn, Fred G. Barker, William T. Curry, Fred H. Hochberg, Daniel P. Cahill, Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th Annual Frye-Halloran Brain Tumor Symposium, Neurosurgical Focus, 2013, 34, 2, E9

    CrossRef

  43. 43
    Mario L. Suvà, David N. Louis, Next-generation molecular genetics of brain tumours, Current Opinion in Neurology, 2013, 26, 6, 681

    CrossRef

  44. 44
    Laure Thomas, Anna L. Di Stefano, François Ducray, Predictive biomarkers in adult gliomas, Current Opinion in Oncology, 2013, 25, 6, 689

    CrossRef

  45. 45
    Marta Mellai, Angela Piazzi, Valentina Caldera, Laura Annovazzi, Oriana Monzeglio, Rebecca Senetta, Paola Cassoni, Davide Schiffer, Promoter Hypermethylation of theEMP3Gene in a Series of 229 Human Gliomas, BioMed Research International, 2013, 2013, 1

    CrossRef

  46. 46
    Jason T Huse, Kenneth D Aldape, The molecular landscape of diffuse glioma and prospects for biomarker development, Expert Opinion on Medical Diagnostics, 2013, 7, 6, 573

    CrossRef

  47. 47
    Yongzhi Wang, Tao Jiang, Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management, Cancer Letters, 2013, 331, 2, 139

    CrossRef

  48. 48
    Rimas V. Lukas, Martin Kelly Nicholas, Update in the Treatment of High-grade Gliomas, Neurologic Clinics, 2013, 31, 3, 847

    CrossRef

  49. 49
    Hideyuki Arita, Yoshitaka Narita, Shintaro Fukushima, Kensuke Tateishi, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, V. Peter Collins, Nobutaka Kawahara, Soichiro Shibui, Koichi Ichimura, Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss, Acta Neuropathologica, 2013, 126, 2, 267

    CrossRef

  50. 50
    Craig Horbinski, What do we know about IDH1/2 mutations so far, and how do we use it?, Acta Neuropathologica, 2013, 125, 5, 621

    CrossRef

  51. 51
    Jinghui Zhang, Gang Wu, Claudia P Miller, Ruth G Tatevossian, James D Dalton, Bo Tang, Wilda Orisme, Chandanamali Punchihewa, Matthew Parker, Ibrahim Qaddoumi, Fredrick A Boop, Charles Lu, Cyriac Kandoth, Li Ding, Ryan Lee, Robert Huether, Xiang Chen, Erin Hedlund, Panduka Nagahawatte, Michael Rusch, Kristy Boggs, Jinjun Cheng, Jared Becksfort, Jing Ma, Guangchun Song, Yongjin Li, Lei Wei, Jianmin Wang, Sheila Shurtleff, John Easton, David Zhao, Robert S Fulton, Lucinda L Fulton, David J Dooling, Bhavin Vadodaria, Heather L Mulder, Chunlao Tang, Kerri Ochoa, Charles G Mullighan, Amar Gajjar, Richard Kriwacki, Denise Sheer, Richard J Gilbertson, Elaine R Mardis, Richard K Wilson, James R Downing, Suzanne J Baker, David W Ellison, Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas, Nature Genetics, 2013, 45, 6, 602

    CrossRef

  52. 52
    Adriana Olar, Kenneth D. Aldape, Biomarkers Classification and Therapeutic Decision-Making for Malignant Gliomas, Current Treatment Options in Oncology, 2012, 13, 4, 417

    CrossRef

  53. 53
    Felix Sahm, Christian Koelsche, Jochen Meyer, Stefan Pusch, Kerstin Lindenberg, Wolf Mueller, Christel Herold-Mende, Andreas von Deimling, Christian Hartmann, CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas, Acta Neuropathologica, 2012, 123, 6, 853

    CrossRef

  54. 54
    Fausto J. Rodriguez, Arie Perry, Marc K. Rosenblum, Sherry Krawitz, Kenneth J. Cohen, Doris Lin, Stacy Mosier, Ming-Tseh Lin, Charles G. Eberhart, Peter C. Burger, Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity, Acta Neuropathologica, 2012, 124, 5, 627

    CrossRef

  55. 55
    Michael D. Blough, Mohammad Al-Najjar, Charles Chesnelong, Carmen E. Binding, Alexandra D. Rogers, H. Artee Luchman, John J. Kelly, Larry Fliegel, Olena Morozova, Stephen Yip, Marco Marra, Samuel Weiss, Jennifer A. Chan, J. Gregory Cairncross, DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma, Annals of Neurology, 2012, 71, 6
  56. 56
    McKinsey L. Goodenberger, Robert B. Jenkins, Genetics of adult glioma, Cancer Genetics, 2012, 205, 12, 613

    CrossRef

  57. 57
    Marie Rivera-Zengotita, Anthony T. Yachnis, Gliosis Versus Glioma?, Advances In Anatomic Pathology, 2012, 19, 4, 239

    CrossRef

  58. 58
    Shingo Takano, Yukinari Kato, Tetsuya Yamamoto, Mika Kato Kaneko, Eiichi Ishikawa, Yuta Tsujimoto, Masahide Matsuda, Kei Nakai, Ryo Yanagiya, Shunpei Morita, Koji Tsuboi, Akira Matsumura, Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors, Journal of Neuro-Oncology, 2012, 108, 3, 361

    CrossRef

  59. 59
    Liu-song Yang, Xiao-en Xu, Xiu-ping Liu, Hong Jin, Zhong-qing Chen, Xiao-hui Liu, Yin Wang, Feng-ping Huang, Qian Shi, iTRAQ-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1p, Journal of Proteomics, 2012, 77, 480

    CrossRef

  60. 60
    Manuela Badiali, Vincent Gleize, Sophie Paris, Loredana Moi, Selma Elhouadani, Antonietta Arcella, Roberta Morace, Manila Antonelli, Francesca Romana Buttarelli, Dominique Figarella- Branger, Young-Ho Kim, Hiroko Ohgaki, Karima Mokhtari, Marc Sanson, Felice Giangaspero, KIAA1549-BRAF Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults, Brain Pathology, 2012, 22, 6
  61. 61
    Chetan Bettegowda, Nicholas Papadopoulos, Nishant Agrawal, Mapping genes for oligodendroglioma, Personalized Medicine, 2012, 9, 3, 311

    CrossRef

  62. 62
    Agustí Alentorn, Marc Sanson, Ahmed Idbaih, Oligodendrogliomas, Current Opinion in Oncology, 2012, 24, 6, 687

    CrossRef

  63. 63
    M. Weller, R. Stupp, M. E. Hegi, M. van den Bent, J. C. Tonn, M. Sanson, W. Wick, G. Reifenberger, Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice, Neuro-Oncology, 2012, 14, suppl 4, iv100

    CrossRef

  64. 64
    Damien Ricard, Ahmed Idbaih, François Ducray, Marion Lahutte, Khê Hoang-Xuan, Jean-Yves Delattre, Primary brain tumours in adults, The Lancet, 2012, 379, 9830, 1984

    CrossRef

  65. 65
    Craig Horbinski, Something Old and Something New About Molecular Diagnostics in Gliomas, Surgical Pathology Clinics, 2012, 5, 4, 919

    CrossRef